Mixed-method evaluation study of a targeted mass drug administration of long-acting anti-malarials among children aged 3 months to 15 years in the Bossangoa sub-prefecture, Ouham, Central African Republic, during the COVID-19 pandemic.

Background: In 2020, during the COVID-19 pandemic, Médecins Sans Frontières (MSF) initiated three cycles of dihydroartemisin-piperaquine (DHA-PQ) mass drug administration (MDA) for children aged three months to 15 years within Bossangoa sub-prefecture, Central African Republic. Coverage, clinical impact, and community members perspectives were evaluated to inform the use of MDAs in humanitarian emergencies.

Methods: A household survey was undertaken after the MDA focusing on participation, recent illness among eligible children, and household satisfaction.

[COVID-19: Myth or reality? Note on the case of the city of Bossangoa (Central African Republic)].

In May 2021, Covid-19 infections are present in Bossangoa, Central African Republic, with an apparent low incidence and a low morbidity. The population equates them with a local pathology considered trivial and does not respect the barrier measures decided by the country's authorities.